P3 Health Partners Inc. (PIII) has disclosed a new risk, in the Share Price & Shareholder Rights category.
P3 Health Partners Inc. faces a significant risk of its securities being delisted from the Nasdaq Capital Market due to non-compliance with the Bid Price Rule, which requires a minimum bid price of $1.00 per share. Despite receiving an extension until May 2025 to address this issue, the company has not yet regained compliance and is considering a reverse stock split as a potential remedy. However, there is uncertainty regarding the effectiveness of such a measure, and delisting could result in diminished stock liquidity, reduced market confidence, and challenges in raising capital. The potential delisting also poses a risk of negative publicity and decreased coverage by securities analysts, further impacting investor sentiment.
Overall, Wall Street has a Moderate Buy consensus rating on PIII stock based on 1 Buy and 1 Hold.
To learn more about P3 Health Partners Inc.’s risk factors, click here.
